Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Vivanco

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 6, 2013
Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategiesS Carrera, A Buque, E Azkona, et al.
The Pharmacogenomics Journal|July 13, 2011
Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemiaJ Salazar, A Altés, E del Río, et al.
American Journal of Hematology|March 8, 2013
Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapseCarolina Martínez-Laperche, Ana M Gómez-García, Álvaro Lassaletta, et al.
Anales Espanoles De Pediatria|February 11, 1999
[The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid)]J L Vivanco Martínez, J López Pérez, C Melero Moreno, et al.
Anales Espanoles De Pediatria|January 1, 1996
[The results of treatment by the Madrid Pediatric Oncology Group according to the BFM protocols in non-Hodgkin's B-cell lymphoma and acute B-cell lymphoblastic leukemia in pediatric patients]J L Vivanco Martínez, A García Gscheidle, M E Cela de Julián, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2011
First-line bevacizumab-containing therapy for breast cancer: results in patients aged≥70 years treated in the ATHENA studyL Biganzoli, E Di Vincenzo, Z Jiang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trialD Rayson, T M Suter, C Jackisch, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 6, 2013
Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategiesS Carrera, A Buque, E Azkona, et al.
The Pharmacogenomics Journal|July 13, 2011
Methotrexate consolidation treatment according to pharmacogenetics of MTHFR ameliorates event-free survival in childhood acute lymphoblastic leukaemiaJ Salazar, A Altés, E del Río, et al.
American Journal of Hematology|March 8, 2013
Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapseCarolina Martínez-Laperche, Ana M Gómez-García, Álvaro Lassaletta, et al.
Anales Espanoles De Pediatria|February 11, 1999
[The treatment results in children diagnosed with non-Hodgkin's lymphomas and acute B-cell lymphoblastic leukemias treated by the BFM protocols. The report of the POGM (Pediatric Oncology Group of Madrid)]J L Vivanco Martínez, J López Pérez, C Melero Moreno, et al.
Anales Espanoles De Pediatria|January 1, 1996
[The results of treatment by the Madrid Pediatric Oncology Group according to the BFM protocols in non-Hodgkin's B-cell lymphoma and acute B-cell lymphoblastic leukemia in pediatric patients]J L Vivanco Martínez, A García Gscheidle, M E Cela de Julián, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2011
First-line bevacizumab-containing therapy for breast cancer: results in patients aged≥70 years treated in the ATHENA studyL Biganzoli, E Di Vincenzo, Z Jiang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trialD Rayson, T M Suter, C Jackisch, et al.
Pageof 3